The store will not work correctly when cookies are disabled.
(Z)-2-((1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-6-hydroxybenzofuran-3(2H)-one
ID: ALA4642838
PubChem CID: 156016477
Max Phase: Preclinical
Molecular Formula: C16H10N2O3
Molecular Weight: 278.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1/C(=C/c2c[nH]c3ncccc23)Oc2cc(O)ccc21
Standard InChI: InChI=1S/C16H10N2O3/c19-10-3-4-12-13(7-10)21-14(15(12)20)6-9-8-18-16-11(9)2-1-5-17-16/h1-8,19H,(H,17,18)/b14-6-
Standard InChI Key: VHCZWXXMSGKCKC-NSIKDUERSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
25.9258 -20.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9247 -21.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6327 -21.9926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6309 -20.3552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3396 -20.7604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3398 -21.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1228 -21.8378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6065 -21.1716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1224 -20.5059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3747 -19.7286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1739 -19.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7819 -20.1001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5065 -18.8069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3193 -18.8919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4890 -19.6893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2629 -19.9394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8678 -19.3933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6935 -18.5937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9199 -18.3473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0970 -18.0997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.6458 -19.6433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 15 1 0
14 13 1 0
13 11 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 20 2 0
17 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.27 | Molecular Weight (Monoisotopic): 278.0691 | AlogP: 2.88 | #Rotatable Bonds: 1 |
Polar Surface Area: 75.21 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.65 | CX Basic pKa: 3.25 | CX LogP: 2.15 | CX LogD: 1.96 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.67 | Np Likeness Score: -0.22 |
References
1. Qhobosheane MA, Legoabe LJ, Josselin B, Bach S, Ruchaud S, Petzer JP, Beteck RM.. (2020) Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors., 28 (11): [PMID:32284225] [10.1016/j.bmc.2020.115468] |